Adu, P., Poopola, T., Medvedev, O. N., Collings, S., Mbinta, J., Aspin, C., & Simpson, C. R. (2023). Implications for COVID-19 vaccine uptake: A systematic review. Journal of Infection and Public Health, 16(3), 441–466. https://doi.org/10.1016/j.jiph.2023.01.020

Albert, S. M., Nowalk, M. P., Yonas, M. A., Zimmerman, R. K., & Ahmed, F. (2012). Standing orders for influenza and pneumococcal polysaccharide vaccination: Correlates identified in a national survey of U.S. Primary care physicians. BMC Family Practice, 13(22). https://doi.org/10.1186/1471-2296-13-22

Ashwell, D., Cullinane, J., & Croucher, S. M. (2021). Vaccine hesitancy and support for employer vaccine mandates. Frontiers in Communication, 6. https://doi.org/10.3389/fcomm.2021.780415

Assoumou, S. A., Peterson, A., Ginman, E., James, T., Pierre, C., Hamilton, S., Chapman, S., Goldie, J., Koenig, R., Méndez-Escobar, E., Leaver, H., Graham, R. M., Crichlow, R., Weaver, T., Cotterell, S., Valdez, G., De Las Nueces, D., Scott, N. A., Linas, B. P., & Cherry, P. M. (2022). Addressing inequities in SARS-COV-2 vaccine uptake: The Boston Medical Center Health System experience. Annals of Internal Medicine, 175(6), 879–884. https://doi.org/10.7326/m22-0028

Atanasov, V., Barreto, N., Whittle, J., Meurer, J., Weston, B. W., Luo, Q., Franchi, L., Yuan, A. Y., Zhang, R., & Black, B. (2023). Understanding COVID-19 vaccine effectiveness against death using a novel measure: COVID excess mortality percentage. Vaccines, 11(2), 379. https://doi.org/10.3390/vaccines11020379

Azarpanah, H., Farhadloo, M., Vahidov, R., & Pilote, L. (2021). Vaccine hesitancy: Evidence from an adverse events following immunization database, and the role of cognitive biases. BMC Public Health, 21(1). https://doi.org/10.1186/s12889-021-11745-1

Bekkat-Berkani, R., Wilkinson, T., Buchy, P., Dos Santos, G., Stefanidis, D., Devaster, J. M., & Meyer, N. (2017). Seasonal influenza vaccination in patients with COPD: A systematic literature review. BMC Pulmonary Medicine, 17(1). https://doi.org/10.1186/s12890-017-0420-8

Benedict, K. M., Santibanez, T. A., Black, C. L., Ding, H., Graitcer, S. B., Bridges, C. B., & Kennedy, E. D. (2017). Recommendations and offers for adult influenza vaccination, 2011–2012 season, United States. Vaccine, 35(9), 1353–1361. https://doi.org/10.1016/j.vaccine.2016.04.061

Berkowitz, H. E., & Vann, J. C. J. (2023). Strategies to address COVID-19 vaccine and pregnancy myths. The American Journal of Maternal Child Nursing, 48(4), 215–223. https://doi.org/10.1097/NMC.0000000000000926

Betsch, C., Brewer, N. T., Brocard, P., Davies, P., Gaissmaier, W., Haase, N., Leask, J., Renkewitz, F., Renner, B., Reyna, V. F., Rossmann, C., Sachse, K., Schachinger, A., Siegrist, M., & Stryk, M. (2012). Opportunities and challenges of Web 2.0 for vaccination decisions. Vaccine, 30(25), 3727–3733. https://doi.org/10.1016/j.vaccine.2012.02.025

Black, C. L., O’Halloran, A., Hung, M., Srivastav, A., Lu, P., Garg, S., Jhung, M. A., Fry, A. M., Jatlaoui, T. C., Davenport, E., Burns, E., Reingold, A., Alden, N., Yousey-Hindes, K., Anderson, E. J., Ryan, P., Kim, S., McMahon, M., Bleecker, M., . . . Cummings, C. N. (2022). Vital signs: Influenza hospitalizations and vaccination coverage by race and ethnicity—United States, 2009–10 through 2021–22 influenza seasons. Morbidity and Mortality Weekly Report, 71(43), 1366–1373. https://doi.org/10.15585/mmwr.mm7143e1

Blumenthal-Barby, J. S., & Krieger, H. (2015). Cognitive biases and heuristics in medical decision making: A critical review using a systematic search strategy. Medical Decision Making, 35(4), 539–557. https://doi.org/10.1177/0272989X14547740

Bonanni, P., Steffen, R., Schelling, J., Balaisyte-Jazone, L., Posiuniene, I., Zatoński, M., & Van Damme, P. (2023). Vaccine co-administration in adults: An effective way to improve vaccination coverage. Human Vaccines & Immunotherapeutics, 19(1). https://doi.org/10.1080/21645515.2023.2195786

Breakwell, G. M. (2014). The psychology of risk (2nd ed.). Cambridge University Press.

Brewer, N. T. (2021). What works to increase vaccination uptake. Academic Pediatrics, 21(4), S9–S16. https://doi.org/10.1016/j.acap.2021.01.017

Brewer, N. T., Chapman, G. B., Rothman, A. J., Leask, J., & Kempe, A. (2017). Increasing vaccination: Putting psychological science into action. Psychological Science in the Public Interest, 18(3), 149–207. https://doi.org/10.1177/152910061876052

Broniatowski, D. A., Jamison, A. M., Johnson, N. F., Velasquez, N., Leahy, R., Restrepo, N. J., Dredze, M., & Quinn, S. C. (2020). Facebook pages, the “Disneyland” measles outbreak, and promotion of vaccine refusal as a civil right, 2009–2019. American Journal of Public Health, 110(S3), S312–S318. https://doi.org/10.2105/AJPH.2020.305869

Brown, S. H., Fisher, E. L., Taylor, A. Q., Neuzil, K. E., Trump, S. W., Sack, D. E., Fricker, G. P., & Miller, R. F. (2021). Influenza vaccine community outreach: Leveraging an interprofessional healthcare student workforce to immunize marginalized populations. Preventive Medicine, 147, 106460. https://doi.org/10.1016/j.ypmed.2021.106460

Brunson, E., Schoch-Spana, M., Carnes, M., Hosangadi, D., Long, R., Ravi, S., Taylor, M., Trotochaud, M., Veenema, T. G., & The CommuniVax Coalition. (2021, July 14). Carrying equity in COVID-19 vaccination forward: Guidance informed by communities of color. Johns Hopkins University. https://publichealth.jhu.edu/2021/carrying-equity-in-covid-19-vaccination-forward-guidance-informed-by-communities-of-color

Buchanan, T. (2020). Why do people spread false information online? The effects of message and viewer characteristics on self-reported likelihood of sharing social media disinformation. PLOS One, 15(10), e0239666. https://doi.org/10.1371/journal.pone.0239666

Callaghan, T., Moghtaderi, A., Lueck, J. A., Hotez, P., Strych, U., Dor, A., Fowler, E. F., & Motta, M. (2021). Correlates and disparities of intention to vaccinate against COVID-19. Social Science & Medicine, 272, 113638. https://doi.org/10.1016/j.socscimed.2020.113638

Centers for Disease Control and Prevention (CDC). (n.d.). Guidelines for vaccinating pregnant women. https://www.cdc.gov/vaccines/pregnancy/hcp-toolkit/guidelines.html

———. (2020a). Influenza (flu) vaccines. Last updated September 30, 2021. https://www.cdc.gov/vaccinesafety/vaccines/flu-vaccine.html

———. (2020b, February 10). ACIP shared clinical decision-making recommendations. https://www.cdc.gov/vaccines/acip/acip-scdm-faqs.html

———. (2021). Flu vaccines are important for children. Last updated August 25, 2023. https://www.cdc.gov/flu/highrisk/children.htm

———. (2022a, October 18). Inequities found in flu vaccine uptake. https://www.cdc.gov/media/releases/2022/s1018-vsflu-vaccine.html

———. (2022b, October 28). People at high risk for severe RSV infection. https://www.cdc.gov/rsv/high-risk/index.html

———. (2023a). COVID data tracker. https://covid.cdc.gov/covid-data-tracker/#vaccination-states-jurisdictions

———. (2023b, May 11). Trends in demographic characteristics of people receiving COVID-19 vaccinations in the United States. https://covid.cdc.gov/covid-data-tracker/#vaccination-demographics-trends

———. (2023c, February 22). Flu vaccine provided substantial protection this season. https://www.cdc.gov/flu/spotlights/2022-2023/flu-vaccine-protection.htm

———. (2023d, June 21). Summary of proposed clinical considerations for RSV vaccines. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2023-06-21-23/07-RSV-Adults-Britton-508.pdf

———. (2023e, April 14). Investigating respiratory viruses in the acutely ill (IVY) network. https://www.cdc.gov/flu/vaccines-work/ivy.htm

Cialdini, R. B. (2021). Influence, new and expanded: The psychology of persuasion. HarperCollins.

Clark, L. T., Watkins, L., Piña, I. L., Elmer, M., Akinboboye, O., Gorham, M., Jamerson, B., McCullough, C., Pierre, C., Polis, A.B., Puckrein, G., & Regnante, J. M. (2019). Increasing diversity in clinical trials: Overcoming critical barriers. Current Problems in Cardiology, 44(5), 148–172. https://doi.org/10.1016/j.cpcardiol.2018.11.002

Dada, D., Djiometio, J. N., McFadden, S. M., Demeke, J., Vlahov, D., Wilton, L., Wang, M., & Nelson, L. E. (2022). Strategies that promote equity in COVID-19 vaccine uptake for Black communities: A review. Journal Of Urban Health, 99(1), 15–27. https://doi.org/10.1007/s11524-021-00594-3

Dai, H., Saccardo, S., Han, M. A., Roh, L., Raja, N., Vangala, S., Modi, H., Pandya, S., Sloyan, M., & Croymans, D. M. (2021). Behavioural nudges increase COVID-19 vaccinations. Nature, 597, 404–409. https://doi.org/10.1038/s41586-021-03843-2

Demeke, J., Ramos, S. R., McFadden, S. M., Dada, D., Nguemo Djiometio, J., Vlahov, D., Wilton, L., Wang, M., & Nelson, L. E. (2023). Strategies that promote equity in COVID-19 vaccine uptake for Latinx communities: A review. Journal Of Racial and Ethnic Health Disparities, 10(3), 1349–1357. https://doi.org/10.1007/s40615-022-01320-8

Duvall, A. (2019). Improving influenza vaccination rates among pediatric hematology and oncology inpatients. Pediatric Nursing, 45(3), 142. https://www.proquest.com/scholarly-journals/improving-influenza-vaccination-ratesamong/docview/2244070666/se-2

Ellingson, M. K., Dudley, M. Z., Limaye, R. J., Salmon, D. A., O’Leary, S. T., & Omer, S. B. (2019). Enhancing uptake of influenza maternal vaccine. Expert Review of Vaccines, 18(2), 191–204. https://doi.org/10.1080/14760584.2019.1562907

Ferdinands, J. M., Thompson, M. G., Blanton, L., Spencer, S., Grant, L., & Fry, A. M. (2021). Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research. Vaccine, 39(28), 3678–3695. https://doi.org/10.1016/j.vaccine.2021.05.011

Finnegan, G., Holt, D., English, P. M., Glismann, S., Thomson, A., Salisbury, D. M., Bogaerts, H., & Bonanni, P. (2018). Lessons from an online vaccine communication project. Vaccine 36(44), 6509–6511. https://doi.org/10.1016/j.vaccine.2018.05.007

Flannery, B., Reynolds, S. B., Blanton, L., Santibanez, T. A., O’Halloran, A., Lu, P. J., Chen, J., Foppa, I. M., Gargiullo, P., Bresee, J., Singleton, J. A., & Fry, A. M. (2017). Influenza vaccine effectiveness against pediatric deaths: 2010–2014. Pediatrics, 139(5). https://doi.org/10.1542/peds.2016-4244

Galvão, J. (2021). COVID-19: The deadly threat of misinformation. Lancet Infectious Diseases, 21(5), e114. https://doi.org/10.1016/S1473-3099(20)30721-0

Gilchrist, S. A., Nanni, A., & Levine, O. (2012). Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: An approach for policymakers. American Journal Public Health, 102, 596–605. https://doi.org/10.2105/AJPH.2011.300512

Grohskopf, L. A., Alyanak, E., Broder, K. R., Walter, E. B., Fry, A. M., & Jernigan, D. B. (2019). Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices—

United States, 2019–20 influenza season. Morbidity and Mortality Weekly Report, 68(3), 1–21. https://doi.org/10.15585/mmwr.rr6803a1

Grohskopf, L. A., Blanton, L., Ferdinands, J. M., Chung, J. R., Broder, K. R., Talbot, H. K., Morgan, R. L., & Fry, A. M. (2022). Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2022–23 influenza season. Morbidity and Mortality Weekly Report, 71(1), 1–28. https://doi.org/10.15585/mmwr.rr7101a1

Grohskopf, L.A., Blanton, L.H., Ferdinands, J.M., Chung, J.R., Broder, K.R., & Talbot, H.K. (2023). Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2023–24 influenza season. MMWR Recommendations and Reports, 72(RR-2), 1–25. http://dx.doi.org/10.15585/mmwr.rr7202a1

Guan, M., Li, Y., Scoles, J. D., & Zhu, Y. (2022). COVID-19 message fatigue: How does it predict preventive behavioral intentions and what types of information are people tired of hearing about? Health Communication, 38(8), 1631–1640. https://doi.org/10.1080/10410236.2021.2023385

Hause, A. M., Zhang, B., Yue, X., Marquez, P., Myers, T. R., Parker, C., Gee, J., Su, J. R., Shimabukuro, T. T., & Shay, D. K. (2022). Reactogenicity of simultaneous COVID-19 mRNA booster and influenza vaccination in the US. JAMA Network Open, 5(7), e2222241. https://doi.org/10.1001/jamanetworkopen.2022.22241

Hawk, M., Nowalk, M. P., Moehling, K. K., Pavlik, V. N., Raviotta, J. M., Brown, A. E., Zimmerman, R. K., & Ricci, E. M. (2017). Using a mixed methods approach to examine practice characteristics associated with implementation of an adult immunization intervention using the 4 Pillars Practice Transformation Program. Journal for Healthcare Quality, 39(3), 153–167. https://doi.org/10.1097/jhq.0000000000000071

Hays, A., Schriever, C., Rudzinski, J., Lynch, J. L., Genrich, E., & Schriever, A. (2018). Fostering interprofessional education through a multidisciplinary, community-based pandemic mass vaccination exercise. American Journal of Public Health, 108(3), 358–360. https://doi.org/10.2105/AJPH.2017.304240

Heintzman, J., Bailey, S. R., Hoopes, M., Le, T., Gold, R., O’Malley, J. P., Cowburn, S., Marino, M., Krist, A., & DeVoe, J. E. (2014). Agreement of Medicaid claims and electronic health records for assessing preventive care quality among adults. Journal of the American Medical Informatics Association, 21(4), 720–724. https://doi.org/10.1136/amiajnl-2013-002333

Humiston, S. G., Bennett, N. M., Long, C., Eberly, S., Arvelo, L., Stankaitis, J., & Szilagyi, P. G. (2011). Increasing inner-city adult influenza vaccination rates: A randomized controlled trial. Public Health Reports, 126(Suppl 2), 39–47. https://doi.org/10.1177/00333549111260S206

Hurley, L. P., Beaty, B., Lockhart, S., Gurfinkel, D., Breslin, K., Dickinson, M., Whittington, M. D., Roth, H., & Kempe, A. (2018). RCT of centralized vaccine reminder/recall for adults. American Journal of Preventive Medicine, 55(2), 231–239. https://doi.org/10.1016/j.amepre.2018.04.022

Hussain, A., Ali, S., Ahmed, M., & Hussain, S. (2018). The anti-vaccination movement: A regression in modern medicine. Cureus, 10(7), e2919. https://doi.org/10.7759/cureus.2919

Huth, K., Benchimol, E. I., Aglipay, M., & Mack, D. R. (2015). Strategies to improve influenza vaccination in pediatric inflammatory bowel disease through education and access. Inflammatory Bowel Diseases, 21(8), 1761–1768. https://doi.org/10.1097/mib.0000000000000425

Iwane, M. K., Chaves, S. S., Szilagyi, P. G., Edwards, K. M., Hall, C. B., Staat, M. A., Brown, C., Griffin, M. R., Weinberg, G. A., Poehling, K. A., Prill, M. M., Williams, J. V., & Bridges, C. B. (2013). Disparities between black and white children in hospitalizations associated with acute respiratory illness and laboratory-confirmed influenza and respiratory syncytial virus in 3 US counties—2002–2009. American Journal of Epidemiology, 177(7), 656–665. https://doi.org/10.1093/aje/kws299

Izikson, R., Brune, D., Bolduc, J., Bourron, P., Fournier, M., Moore, T. M., Pandey, A., De Armas Pérez, L., Sater, N., Shrestha, A., Wague, S., & Samson, S. I. (2022). Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: A phase 2, randomised, open-label study. The Lancet Respiratory Medicine, 10(4), 392–402. https://doi.org/10.1016/s2213-2600(21)00557-9

KFF. (2023). KFF COVID-19 vaccine monitor dashboard. https://www.kff.org/coronavirus-covid-19/dashboard/kff-covid-19vaccine-monitor-dashboard/#uptake

Kuehn, B. M. (2021). Influenza vaccination increased during the COVID-19 pandemic. Journal of the American Medical Association, 326(24), 2465. https://doi.org/10.1001/jama.2021.22390

Kuehn, M., LaMori, J., DeMartino, J.K., Mesa-Frias, M., Doran, J., Korrapati, L., Bhojwani, R., Lefebvre, P., & Kirson, N. (2022). Assessing barriers to access and equity for COVID-19 vaccination in the US. BMC Public Health, 22, 1-8. https://doi.org/10.1186/s12889-022-14636-1

Lahijani, A. Y., King, A. R., Gullatte, M. M., Hennink, M., & Bednarczyk, R. A. (2021). HPV vaccine promotion: The church as an agent of change. Social Science & Medicine, 268, 113375. https://doi.org/10.1016/j.socscimed.2020.113375

Lau, C. Y., Stansbury, J. P., Gust, D. A., & Kafaar, Z. (2009). Social and behavioral science in HIV vaccine trials: A gap assessment of the literature. Expert Review of Vaccines, 8, 179–190. https://doi.org/10.1586/14760584.8.2.179

Lau, D., Hu, J., Majumdar, S. R., Storie, D. A., Rees, S. E., & Johnson, J. A. (2012). Interventions to improve influenza and pneumococcal vaccination rates among community-dwelling adults: A systematic review and meta-analysis. Annals of Family Medicine, 10(6), 538–546. https://doi.org/10.1370/afm.1405

Larson, H.J., Cooper, L.Z., Eskola, J., Katz, S.L., & Ratzan, S. (2011). Addressing the vaccine confidence gap. Lancet, 378(9790), 526–535. https://doi.org/10.1016/S0140-6736(11)60678-8.

Lazarus, R., Baos, S., Cappel-Porter, H., Carson-Stevens, A., Clout, M., Culliford, L., Emmett, S. R., Garstang, J., Gbadamoshi, L., Hallis, B., Harris, R. A., Hutton, D., Jacobsen, N., Joyce, K., Kaminski, R., Libri, V., Middleditch, A., McCullagh, L., Moran, E., . . . Rogers, C. (2021). Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): A multicentre, randomised, controlled, phase 4 trial. The Lancet, 398(10318), 2277–2287. https://doi.org/10.1016/s0140-6736(21)02329-1

LeBlanc, M., Ruane, K., Fairbanks, M., & Roy, B. (2021). State strategies to increase vaccine uptake in rural communities. National Governors Association Center for Best Practices. https://www.nga.org/wpcontent/uploads/2021/08/NGA_Rural-Communities_Covid-19-Vaccine.pdf

Lee, S. K., Sun, J., Jang, S., & Connelly, S. (2022). Misinformation of COVID-19 vaccines and vaccine hesitancy. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-17430-6

Lipkind, H. S., Vazquez-Benitez, G., DeSilva, M., Vesco, K. K., Ackerman-Banks, C., Zhu, J., Boyce, T. G., Daley, M. F., Fuller, C. C., Getahun, D., Irving, S. A., Jackson, L. A., Williams, J. T. B., Zerbo, O., McNeil, M. M., Olson, C. K., Weintraub, E., & Kharbanda, E. O. (2022). Receipt of COVID-19 vaccine during pregnancy and preterm or small-for-gestational-age at birth—Eight integrated health care organizations, United States, December 15, 2020-July 22, 2021. Morbidity and Mortality Weekly Report, 71(1), 26–30. https://doi.org/10.15585/mmwr.mm7101e1

Lu, P. J., O’Halloran, A., & Williams, W. W. (2015a). Impact of health insurance status on vaccination coverage among adult populations. American Journal of Preventive Medicine, 48(6), 647–661. https://doi.org/10.1016/j.amepre.2014.12.008

Lu, P. J., O’Halloran, A., Williams, W. W., Lindley, M. C., Farrall, S., & Bridges, C. B. (2015b). Racial and ethnic disparities in vaccination coverage among adult populations in the U.S. American Journal of Preventive Medicine, 49(6 Suppl 4), S412–S425. https://doi.org/10.1016/j.amepre.2015.03.005

MacDonald, N. E. (2015). Vaccine hesitancy: Definition, scope, and determinants. Vaccine, 33(34), 4161–4164. https://doi.org/10.1016/j.vaccine.2015.04.036

McConeghy, K. W., White, E. M., Blackman, C., Santostefano, C. M., Lee, Y., Rudolph, J. L., Canaday, D., Zullo, A. R., Jernigan, J. A., Pilishvili, T., Mor, V., & Gravenstein, S. (2022). Effectiveness of a second COVID-19 vaccine booster dose against infection, hospitalization, or death among nursing home residents—19 States, March 29–July 25, 2022. Morbidity and Mortality Weekly Report, 71(39), 1235–1238. https://doi.org/10.15585/mmwr.mm7139a2

Melgar, M., Britton, A., Roper, L. E., Talbot, H. K., Long, S. S., Kotton, C. N., & Havers, F. (2023). Use of respiratory syncytial virus vaccines in older adults: Recommendations of the Advisory Committee on Immunization Practices—United States, 2023. Morbidity and Mortality Weekly Report, 72(29), 793–801. https://doi.org/10.15585/mmwr.mm7229a4

Moro, P., Baumblatt, J., Lewis, P., Cragan, J., Tepper, N., & Cano, M. (2017). Surveillance of adverse events after seasonal influenza vaccination in pregnant women and their infants in the Vaccine Adverse Event Reporting System, July 2010–May 2016. Drug Safety, 40, 145–152. https://doi.org/10.1007/s40264-016-0482-1

Moro, P. L., Olson, C. K., Clark, E., Marquez, P., Strid, P., Ellington, S., Zhang, B., Mba-Jonas, A., Alimchandani, M., Cragan, J., & Moore, C. (2022). Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 - October 2021. Vaccine, 40(24), 3389–3394. https://doi.org/10.1016/j.vaccine.2022.04.031.

Motta, M. (2021). Republicans, not Democrats, are more likely to endorse anti-vaccine misinformation. American Politics Research, 49(5), 428–438. https://doi.org/10.1177/1532673X211022639

Motta, M., Sylvester, S., Callaghan, T., & Lunz-Trujillo, K. (2021). Encouraging COVID-19 vaccine uptake through effective health communication. Frontiers in Political Science, 3. https://doi.org/10.3389/fpos.2021.630133

National Academies of Sciences, Engineering, and Medicine (NASEM). (2017). Communicating science effectively: A research agenda. The National Academies Press. https://doi.org/10.17226/23674

———. (2020). Framework for equitable allocation of COVID-19 vaccine. National Academies Press. https://doi.org/10.17226/25917

———. (2021a). Understanding and communicating about COVID-19 vaccine efficacy, effectiveness, and equity. The National Academies Press. https://doi.org/10.17226/26154

———. (2021b). Strategies for building confidence in the COVID-19 vaccines. The National Academies Press. https://doi.org/10.17226/26068

———. (2021c). Communication strategies for building confidence in COVID-19 vaccines: Addressing variants and childhood vaccinations. The National Academies Press. https://doi.org/10.17226/26361

National Vaccine Advisory Committee. (2014). Recommendations from the National Vaccine Advisory committee: Standards for adult immunization practice. Public Health Reports, 129(2), 115–123. https://doi.org/10.1177/003335491412900203

Neely, S. R., Eldredge, C., Ersing, R., & Remington, C. (2022). Vaccine hesitancy and exposure to misinformation: A survey analysis. Journal of General Internal Medicine, 37(1), 179–187. https://doi.org/10.1007/s11606-021-07171-z

Njoku, A., Joseph, M., & Felix, R. (2021). Changing the narrative: Structural barriers and racial and ethnic inequities in COVID-19 vaccination. International Journal of Environmental Research and Public Health, 18(18), 9904. https://doi.org/10.3390/ijerph18189904

Nowalk, M. P., Nolan, B., Nutini, J., Ahmed, F., Albert, S. M., Susick, M., & Zimmerman, R. K. (2014). Success of the 4 Pillars Toolkit for influenza and pneumococcal vaccination in adults. Journal for Healthcare Quality, 36(6), 5–15. https://doi.org/10.1111/jhq.12020

Nyhan, B., & Reifler, J. (2015). Does correcting myths about the flu vaccine work? An experimental evaluation of the effects of corrective information. Vaccine, 33(3), 459–464. https://doi.org/10.1016/j.vaccine.2014.11.017

Nypaver, C. F., Dehlinger, C., & Carter, C. (2021). Influenza and influenza vaccine: A review. Journal of Midwifery & Women’s Health, 66(1), 45–53. https://doi.org/10.1111/jmwh.13203

O’Halloran, A., Lu, P., Williams, W. W., Schumacher, P. K., Sussell, A., Birdsey, J., Boal, W. L., Sweeney, M. H., Luckhaupt, S. E., Black, C. L., & Santibanez, T. A. (2017). Influenza vaccination among workers—21 U.S. states, 2013. American Journal of Infection Control, 45(4), 410–416. https://doi.org/10.1016/j.ajic.2017.01.005

Olson, S. M., Newhams, M. M., Halasa, N., Feldstein, L. R., Novak, T., Weiss, S. L., Coates, B. M., Schuster, J. E., Schwarz, A., Maddux, A. B., Hall, M. W., Nofziger, R. A., Flori, H. R., Gertz, S. J., Kong, M., Sanders, R. C., Irby, K., Hume, J. R., Cullimore, M. L., . . . Randolph, A. G. (2022). Vaccine effectiveness against life-threatening influenza illness in US children. Clinical Infectious Diseases, 75(2), 230–238. https://doi.org/10.1093/cid/ciab931

Organisation for Economic Co-operation and Development. (2020, July 3). Transparency, communication and trust: The role of public communication in responding to the wave of disinformation about the new coronavirus. https://www.oecd.org/coronavirus/policy-responses/transparency-communication-and-trust-the-role-of-publiccommunication-in-responding-to-the-wave-of-disinformation-about-the-new-coronavirus-bef7ad6e/

Panda, B., Stiller, R., & Panda, A. (2011). Influenza vaccination during pregnancy and factors for lacking compliance with current CDC guidelines. Journal of Maternal-Fetal & Neonatal Medicine, 24(3), 402–406. https://doi.org/10.3109/14767058.2010.497882

Papi, A., Ison, M. G., Langley, J. M., Lee, D. G., Leroux-Roels, I., Martinón-Torres, F., Schwarz, T. F., Van Zyl-Smit, R. N., Campora, L., Dezutter, N., De Schrevel, N., Fissette, L., David, M., Van Der Wielen, M., Kostanyan, L., & Hulstrøm, V. (2023). Respiratory syncytial virus prefusion F protein vaccine in older adults. The New England Journal of Medicine, 388(7), 595–608. https://doi.org/10.1056/nejmoa2209604

Peña, J. M., Schwartz, M. R., Hernandez-Vallant, A., & Sanchez, G. R. (2023). Social and structural determinants of COVID-19 vaccine uptake among racial and ethnic groups. Journal of Behavioral Medicine, 46(1–2), 129–139. https://doi.org/10.1007/s10865-023-00393-y

Petersen, M. B., Bor, A., Jørgensen, F., & Lindholt, M. F. (2021). Transparent communication about negative features of COVID-19 vaccines decreases acceptance but increases trust. Proceedings of the National Academy of Sciences of the United States of America, 118(29), e2024597118. https://doi.org/10.1073/pnas.2024597118

Phillips, R., Gillespie, D., Hallingberg, B., Evans, J., Taiyari, K., Torrens-Burton, A., Cannings-John, R., Williams, D., Sheils, E., Ashfield-Watt, P., Akbari, A., Hughes, K., Thomas-Jones, E., James, D., & Wood, F. (2022). Perceived threat of COVID-19, attitudes towards vaccination, and vaccine hesitancy: A prospective longitudinal study in the U.K. British Journal of Health Psychology, 27(4), 1354–1381. https://doi.org/10.1111/bjhp.12606

Putri, W. C. W. S., Muscatello, D., Stockwell, M. S., & Newall, A. T. (2018). Economic burden of seasonal influenza in the United States. Vaccine, 36(27), 3960–3966. https://doi.org/10.1016/j.vaccine.2018.05.057

Qeadan, F., VanSant-Webb, E., Tingey, B., Rogers, T. N., Brooks, E., Mensah, N. A., Winkfield, K. M., Saeed, A. I., English, K., & Rogers, C. R. (2021). Racial disparities in COVID-19 outcomes exist despite comparable Elixhauser comorbidity indices between Blacks, Hispanics, Native Americans, and Whites. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-88308-2

Rabb, N., Swindal, M., Glick, D., Bowers, J., Tomasulo, A., Oyelami, Z., Wilson, K. H., & Yokum, D. (2022). Evidence from a statewide vaccination RCT shows the limits of nudges. Nature, 604(7904), E1–E7. https://doi.org/10.1038/s41586-022-04526-2

Rawal, S., Tackett, R. L., Stone, R. H., & Young, H. N. (2022). COVID-19 vaccination among pregnant people in the United States: a systematic review. American Journal of Obstetrics & Gynecology, 4(4), 1–13. https://doi.org/10.1016/j.ajogmf.2022.100616

Schneeberg, A., Bettinger, J.A., McNeil, S., Ward, B.J., Dionne, M., Cooper, C., Coleman, B., Loeb, M., Rubinstein, E., McElhaney, J., Scheifele, D.W., & Halperin, S.A. (2014). Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation. BMC Public Health, 14(1), 1-9. https://doi.org/10.1186/1471-2458-14-442.

Schumacher, S., Sparks, G., Presiado, M., Kirzinger, A., & Brodie, M. (2023, February 7). KFF COVID-19 vaccine monitor: January 2023. https://www.kff.org/coronavirus-covid-19/poll-finding/kff-covid-19-vaccine-monitor-january-2023/

Shen, A. K., Browne, S., Srivastava, T., Kornides, M. L., & Tan, A. S. L. (2023). Trusted messengers and trusted messages: The role for community-based organizations in promoting COVID-19 and routine immunizations. Vaccine, 41(12), 1994–2002. https://doi.org/10.1016/j.vaccine.2023.02.045

Shimabukuro, T.T., Kim, S.Y., Myers, T. R., Moro, P.L., Oduyebo, T., Panagiotakopoulos, L., Marquez, P. L., Olson, C.K., Liu, R., Chang, K. T., Ellington, S. R., Burkel, V. K., Smoots, A. N., Green, C. J., Licata, C., Zhang, B. C., Alimchandani, M., Mba-Jonas, A., Martin, S. W., Gee, J. M., … CDC v-safe COVID-19 Pregnancy Registry Team (2021). Preliminary Findings of mRNA COVID-19 Vaccine Safety in Pregnant Persons. The New England Journal of Medicine, 384(24), 2273–2282. https://doi.org/10.1056/NEJMoa2104983

Skafle, I., Nordahl-Hansen, A., Quintana, D. S., Wynn, R., & Gabarron, E. (2022). Misinformation about COVID-19 vaccines on social media: Rapid review. Journal of Medical Internet Research, 24(8), e37367. https://doi.org/10.2196/37367

Skibinski, D. A., Baudner, B. C., Singh, M., & O’Hagan, D. T. (2011). Combination vaccines. Journal of Global Infectious Diseases, 3(1), 63–72. https://doi.org/10.4103/0974-777X.77298

Surie, D., DeCuir, J., Zhu, Y., Gaglani, M., Ginde, A. A., Douin, D. J., Talbot, H. K., Casey, J. D., Mohr, N. M., Zepeski, A., McNeal, T., Ghamande, S., Gibbs, K. W., Files, D. C., Hager, D. N., Ali, H., Taghizadeh, L., Gong, M. N., Mohamed, A., . . . Self, W. H. (2022). Early Estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19–associated hospitalization among immunocompetent adults aged ≥65 years—IVY Network, 18 states, September 8–November 30, 2022. Morbidity and Mortality Weekly Report, 71(5152), 1625–1630. https://doi.org/10.15585/mmwr.mm715152e2

Swamy, G.K., & Heine, R.P. (2015). Vaccinations for pregnant women. Obstetrics and Gynecology, 125(1), 212–226. https://doi.org/10.1097/AOG.0000000000000581.

Taylor, S. L., & Lurie, N. (2004). The role of culturally competent communication in reducing ethnic and racial healthcare disparities. American Journal of Managed Care, 10, SP1–SP4. https://pubmed.ncbi.nlm.nih.gov/15481430

Thomas, R. E., & Lorenzetti, D. L. (2018). Interventions to increase influenza vaccination rates of those 60 years and older in the community. The Cochrane Database of Systematic Reviews, 5(5), CD005188. https://doi.org/10.1002/14651858.CD005188.pub4

Toback, S., Galiza, E., Cosgrove, C., Galloway, J., Goodman, A., Swift, P. A., Rajaram, S., Graves-Jones, A., Edelman, J. M., Burns, F., Minassian, A. M., Cho, I., Kumar, L. D., Plested, J. S., Rivers, E., Robertson, A., Dubovsky, F., Glenn, G., & Heath, P. T. (2022). Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: An exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial. The Lancet Respiratory Medicine, 10(2), 167–179. https://doi.org/10.1016/s2213-2600(21)00409-4

U.S. Food and Drug Administration. (2011). Communicating risks and benefits: An evidence-based user’s guide. http://www.fda.gov/AboutFDA/ReportsManualsForms/Reports/ucm268078.htm

Vahidy, F. S., Nicolas, J. C., Meeks, J. R., Khan, O., Pan, A., Jones, S. L., Masud, F., Sostman, H. D., Phillips, R., Andrieni, J. D., Kash, B. A., & Nasir, K. (2020). Racial and ethnic disparities in SARS-CoV-2 pandemic: Analysis of a COVID-19 observational registry for a diverse U.S. metropolitan population. BMJ Open, 10(8), e039849. https://doi.org/10.1136/bmjopen-2020-039849

Van der Linden, S. L., Clarke, C. E., & Maibach, E. W. (2015). Highlighting consensus among medical scientists increases public support for vaccines: Evidence from a randomized experiment. BMC Public Health, 15(1). https://doi.org/10.1186/s12889-015-2541-4

Viswanath, K., Bekalu, M., Dhawan, D., Pinnamaneni, R., Lang, J., & McLoud, R. (2021a). Individual and social determinants of COVID-19 vaccine uptake. BMC Public Health, 21(1). https://doi.org/10.1186/s12889-021-10862-1

Viswanath, K., McCloud, R. F., & Bekalu, M. A. (2021b). Communication, health, and equity: Structural influences. In T. L. Thompson & N. Grant Harrington (Eds.) The Routledge Handbook of Health Communication (pp. 426–440). Routledge.

Vlahov, D., Coady, M. H., Ompad, D. C., & Galea, S. (2007). Strategies for improving influenza immunization rates among hard-to-reach populations. Journal of Urban Health, 84(4), 615–631. https://doi.org/10.1007/s11524-007-9197-z

Vraga, E. K., & Bode, L. (2017). Using expert sources to correct health misinformation in social media. Science Communication, 39(5), 621–645. https://doi.org/10.1177/1075547017731776

Vraga, E. K., & Bode, L. (2020). Defining misinformation and understanding its bounded nature: Using expertise and evidence for describing misinformation. Political Communication, 37(1), 136–144. https://doi.org/10.1080/10584609.2020.1716500

Walsh, E. E., Marc, G. P., Zareba, A. M., Falsey, A. R., Jiang, Q., Patton, M. Q., Polack, F. P., Llapur, C. J., Doreski, P. A., Ilangovan, K., Rämet, M., Fukushima, Y., Hussen, N., Bont, L., Cardona, J., DeHaan, E., Villa, G. C., Ingilizova, M., Eiras, D. P., . . . Schmoele-Thoma, B. (2023). Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults. The New England Journal of Medicine, 388(16), 1465–1477. https://doi.org/10.1056/nejmoa2213836

Williamson, K., Greene, K., LeBlanc, M., Roy, B., & Tewarson, H. (2021, June 7). State strategies for engaging and leveraging primary care providers as COVID-19 vaccinators. National Governors Association Center for Best Practices. https://www.nga.org/center/publications/state-strategies-for-engaging-and-leveraging-primary-careproviders-as-covid-19-vaccinators

Yudin, M. H., Mistry, N., De Souza, L. R., Besel, K., Patel, V. C., Mejia, S. B., Bernick, R., Ryan, V., Urquia, M. L., Beigi, R. H., Moniz, M. H., & Sgro, M. (2017). Text messages for influenza vaccination among pregnant women: A randomized controlled trial. Vaccine, 35(5), 842–848. https://doi.org/10.1016/j.vaccine.2016.12.002

Zimmerman, R. K., Nowalk, M. P., Tabbarah, M., Hart, J., Fox, D. E., & Raymund, M. (2009). Understanding adult vaccination in urban, lower-socioeconomic settings: Influence of physician and prevention systems. Annals of Family Medicine, 7(6), 534–541. https://doi.org/10.1370/afm.1060

Zimmerman, R. K., Brown, A. E., Pavlik, V. N., Moehling, K. K., Raviotta, J. M., Lin, C. J., Zhang, S., Hawk, M., Kyle, S., Patel, S., Ahmed, F., & Nowalk, M. P. (2017). Using the 4 Pillars Practice Transformation Program to increase pneumococcal immunizations for older adults: A cluster-randomized trial. Journal of the American Geriatrics Society, 65(1), 114–122. https://doi.org/10.1111/jgs.14451